Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial

Overview of attention for article published in The Lancet Respiratory Medicine, March 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 5 news outlets
policy: 1 policy source

twitter: 6 X users
guideline: 4 clinical guideline sources

Readers on

mendeley: 182 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 33,069 followers.

@Brian34Schroer @RobynCohenMD In this SMART trial, annual prednisone-equivalent exposure was the same as in standard therapy, as daily budesonide use increased in SMART. Exacerbations requiring steroids were predictably higher in standard therapy, but h…

Maintenance & reliever budesonide–formoterol inhaler in asthma pts at risk of exacerbations, free access til Mar 14 http://t.co/ZVgymHhnFu

Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma… http://t.co/mYFczUp2L1

Maintenance and reliever combo budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations http://t.co/Ekf8yx8k96

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.